18.16
price up icon0.44%   0.02
after-market アフターアワーズ: 18.16
loading
前日終値:
$18.18
開ける:
$18.39
24時間の取引高:
175.22K
Relative Volume:
0.78
時価総額:
$1.07B
収益:
-
当期純損益:
$-147.32M
株価収益率:
-3.4438
EPS:
-5.2733
ネットキャッシュフロー:
$-122.10M
1週間 パフォーマンス:
-1.35%
1か月 パフォーマンス:
-7.78%
6か月 パフォーマンス:
+41.50%
1年 パフォーマンス:
+117.12%
1日の値動き範囲:
Value
$18.13
$18.66
1週間の範囲:
Value
$18.03
$18.90
52週間の値動き範囲:
Value
$7.5262
$26.18

Dbv Technologies Adr Stock (DBVT) Company Profile

Name
名前
Dbv Technologies Adr
Name
セクター
Healthcare (1113)
Name
電話
33(0)155427878
Name
住所
107 AVENUE DE LA REPUBLIQUE, CHATILLON
Name
職員
161
Name
次回の収益日
2026-04-29
Name
最新のSEC提出書
Name
DBVT's Discussions on Twitter

Compare DBVT vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
DBVT icon
DBVT
Dbv Technologies Adr
18.16 1.08B 0 -147.32M -122.10M -5.2733
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
435.92 110.28B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
634.42 66.98B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
808.61 50.15B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
295.50 39.71B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
154.89 32.22B 742.00K -1.37B -1.07B -7.0731

Dbv Technologies Adr Stock (DBVT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-15 開始されました Cantor Fitzgerald Overweight
2025-12-03 開始されました Guggenheim Buy
2025-05-29 再開されました Goldman Sell
2023-01-04 アップグレード Societe Generale Hold → Buy
2022-12-16 ダウングレード Goldman Neutral → Sell
2022-05-10 ダウングレード Goldman Buy → Neutral
2021-09-14 アップグレード Societe Generale Hold → Buy
2021-01-22 ダウングレード Societe Generale Hold → Sell
2020-11-02 アップグレード Societe Generale Sell → Hold
2020-08-06 ダウングレード Societe Generale Buy → Sell
2020-08-05 繰り返されました H.C. Wainwright Buy
2020-03-17 ダウングレード Stifel Buy → Hold
2020-01-09 アップグレード Stifel Hold → Buy
2019-12-16 開始されました Citigroup Buy
2019-09-05 再開されました Morgan Stanley Equal-Weight
2019-06-17 開始されました Goldman Buy
2018-12-20 ダウングレード Barclays Overweight → Equal Weight
2018-12-20 ダウングレード BofA/Merrill Buy → Underperform
2018-12-20 ダウングレード Jefferies Buy → Hold
2018-12-20 ダウングレード Stifel Buy → Hold
2017-10-31 アップグレード Societe Generale Sell → Hold
2017-10-24 ダウングレード Societe Generale Buy → Sell
2017-10-23 ダウングレード Morgan Stanley Overweight → Equal-Weight
2017-06-23 開始されました Deutsche Bank Buy
2017-03-16 アップグレード Societe Generale Hold → Buy
2016-09-26 開始されました JMP Securities Mkt Outperform
2015-12-03 開始されました Barclays Overweight
2015-10-23 開始されました BofA/Merrill Buy
すべてを表示

Dbv Technologies Adr (DBVT) 最新ニュース

pulisher
May 15, 2026

MPM BioImpact reports 8.8% stake in DBV Technologies (DBVT) - Stock Titan

May 15, 2026
pulisher
May 14, 2026

Combined General Meeting of June 3, 2026 - The Manila Times

May 14, 2026
pulisher
May 13, 2026

Adage insiders report 22,272,884 shares in DBV Technologies (NASDAQ: DBVT) - Stock Titan

May 13, 2026
pulisher
May 13, 2026

Artisan Partners (DBVT) discloses 2,219,386 ADS; 3.7% stake reported - Stock Titan

May 13, 2026
pulisher
May 12, 2026

Vivo Opportunity (DBVT) holds 2.36M ADSs — 4.0% ownership disclosed - Stock Titan

May 12, 2026
pulisher
May 12, 2026

DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq - The Manila Times

May 12, 2026
pulisher
May 05, 2026

DBV Technologies (DBVT) grants 1.74M performance share units to CEO - Stock Titan

May 05, 2026
pulisher
May 05, 2026

Invus affiliates disclose 17.998M DBV ordinary shares (DBVT) — 6.1% reported - Stock Titan

May 05, 2026
pulisher
May 01, 2026

DBVT Stock Price, Quote & Chart | DBV TECHNOLOGIES SA-SPON ADR (NASDAQ:DBVT) - ChartMill

May 01, 2026
pulisher
Apr 30, 2026

symbol__ Stock Quote Price and Forecast - CNN

Apr 30, 2026
pulisher
Apr 30, 2026

DBV Technologies (DBVT) ramps Q1 2026 spending but extends cash runway - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

DBV Technologies Reports First Quarter 2026 Financial Results - The Manila Times

Apr 30, 2026
pulisher
Apr 24, 2026

Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Apr 24, 2026
pulisher
Apr 16, 2026

DBV Technologies (NASDAQ: DBVT) director Philina Lee files initial Form 3 ownership - Stock Titan

Apr 16, 2026
pulisher
Apr 14, 2026

Wall Street Analysts Predict a 79.04% Upside in DBV Technologies (DBVT): Here's What You Should Know - Zacks Investment Research

Apr 14, 2026
pulisher
Apr 13, 2026

Eosinophilic Esophagitis Market in the US to Grow at 13.2% CAGR During the Forecast Period (2026–2036) Owing to the Emergence of Drug Classes Such as TSLP Inhibitors, Glucocorticoid Receptor Agonists, and Immunomodulators | DelveInsight - GlobeNewswire Inc.

Apr 13, 2026
pulisher
Apr 11, 2026

Goldman Sachs Keeps Their Sell Rating on DBV Technologies SA – American (DBVT) - The Globe and Mail

Apr 11, 2026
pulisher
Apr 09, 2026

Combined General Meeting of June 11, 2025 - NTB Kommunikasjon

Apr 09, 2026
pulisher
Apr 07, 2026

Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail

Apr 07, 2026
pulisher
Apr 03, 2026

DBV technologies S.A. (ADR) (DBV1.SG) Stock Forum & Discussion - Yahoo! Finance Canada

Apr 03, 2026
pulisher
Apr 03, 2026

DBV technologies S.A. (ADR) (DBV1.SG) Stock Major Holders - Yahoo! Finance Canada

Apr 03, 2026
pulisher
Apr 03, 2026

DBV Technologies (DBVT) Projected to Post Quarterly Earnings on Friday - Defense World

Apr 03, 2026
pulisher
Apr 02, 2026

DBV technologies S.A. (ADR) (DBV1.SG) company profile and facts - Yahoo Finance UK

Apr 02, 2026
pulisher
Mar 30, 2026

DBV Technologies: A Tough Nut To Crack In A Shrinking Market (NASDAQ:DBVT) - Seeking Alpha

Mar 30, 2026
pulisher
Mar 29, 2026

Guggenheim Reiterates “Buy” Rating for DBV Technologies (NASDAQ:DBVT) - Defense World

Mar 29, 2026
pulisher
Mar 27, 2026

Alphabet To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga

Mar 27, 2026
pulisher
Mar 26, 2026

DBV Technologies Reports Full Year 2025 Financial Results and Business Update - markets.businessinsider.com

Mar 26, 2026
pulisher
Mar 26, 2026

DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - The Manila Times

Mar 26, 2026
pulisher
Mar 26, 2026

DBV Technologies (NASDAQ: DBVT) deepens 2025 loss but funds runway into 2027 - Stock Titan

Mar 26, 2026
pulisher
Mar 26, 2026

Peanut patch developer DBV says cash funds operations into Q2 2027 - Stock Titan

Mar 26, 2026
pulisher
Mar 25, 2026

Hesai Group, BitFuFu And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm

Mar 25, 2026
pulisher
Mar 25, 2026

DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - The Manila Times

Mar 25, 2026
pulisher
Mar 09, 2026

DLD Asset Management LP Makes New $250,000 Investment in DBV Technologies S.A. $DBVT - Defense World

Mar 09, 2026
pulisher
Mar 07, 2026

Analysts Offer Insights on Healthcare Companies: ArriVent BioPharma, Inc. (AVBP), Chemomab Therapeutics (CMMB) and Reviva Pharmaceuticals Holdings (RVPH) - The Globe and Mail

Mar 07, 2026
pulisher
Mar 05, 2026

DBV Technologies to Participate in Upcoming March Investor Conferences - The Manila Times

Mar 05, 2026
pulisher
Mar 04, 2026

Biotech DBV Technologies lines up back-to-back March investor events - Stock Titan

Mar 04, 2026
pulisher
Mar 03, 2026

Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 - ChartMill

Mar 03, 2026
pulisher
Mar 03, 2026

Guggenheim Sticks to Their Buy Rating for DBV Technologies SA – American (DBVT) - The Globe and Mail

Mar 03, 2026
pulisher
Mar 02, 2026

DBV Technologies stock surges on new peanut patch trial data - Investing.com

Mar 02, 2026
pulisher
Mar 02, 2026

Phase 3 VITESSE data highlighted by DBV Technologies (NASDAQ: DBVT) - Stock Titan

Mar 02, 2026
pulisher
Mar 01, 2026

DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting - The Manila Times

Mar 01, 2026
pulisher
Feb 28, 2026

DBV Technologies Highlights Additional Data from Successful - GlobeNewswire

Feb 28, 2026
pulisher
Feb 26, 2026

DBV Technologies (DBVT) Projected to Post Earnings on Thursday - Defense World

Feb 26, 2026
pulisher
Feb 25, 2026

European ADRs Were Flat As Biotech Names Took The Lead - Finimize

Feb 25, 2026
pulisher
Feb 25, 2026

Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA) and Palvella Therapeutics (PVLA) - The Globe and Mail

Feb 25, 2026

Dbv Technologies Adr (DBVT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Dbv Technologies Adr (DBVT) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
EPIC Bpifrance
Member of 10% owner group
Dec 17 '25
Sale
4.85
2,076,990
10,070,232
8,595,472
EPIC Bpifrance
Member of 10% owner group
Dec 18 '25
Sale
4.19
1,292,103
5,413,912
7,303,369
Mohideen Pharis
Chief Medical Officer
Nov 20 '25
Sale
2.88
6,496
18,708
103,153
Mohideen Pharis
Chief Medical Officer
Nov 21 '25
Sale
2.77
1,624
4,498
101,529
Mohideen Pharis
Chief Medical Officer
Jul 29 '25
Sale
2.22
464
1,030
109,649
$29.66
price down icon 1.49%
$92.29
price up icon 0.12%
$108.87
price up icon 2.60%
$53.85
price down icon 0.94%
ONC ONC
$302.59
price down icon 2.50%
$154.89
price up icon 2.21%
大文字化:     |  ボリューム (24 時間):